ACC Online Courses offer the cardiovascular community a collection of resources and newly developed, evidence-based educational activities across topics such as lipid management, valvular heart ...

What an amazing year 2024 was in terms of advances in cardiovascular care! With more than 882,000 users, ACC.org continues to be a critical resource for cardiovascular clinicians around the world! The ...

Join a community dedicated to innovative cardiovascular care, where every role contributes to our mission of transforming heart health. Explore opportunities that not only advance your career but also ...

Early increases in CRP during immune checkpoint inhibitor (ICI) therapy are linked to a higher risk of venous thromboembolism (VTE). CRP trajectories could serve as biomarkers for assessing VTE risk ...

Multimodality imaging can identify papillary muscles that are the source of arrhythmias. Increased echogenicity, gadolinium enhancement, and calcifications on papillary muscles can indicate site of ...

The following are key points to remember from a state-of-the-art review on cardiovascular (CV) risk in prostate cancer (PC): ...

Chlorthalidone is not superior to hydrochlorothiazide in preventing kidney disease progression in patients with hypertension. Chlorthalidone causes slightly more hypokalemia than hydrochlorothiazide.

Login to subscribe for notifications.

Please get in touch with Michael Phillips for additional information, at mphillips@acc.org.

In this week’s View, Dr. Eagle looks at the 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis. He then discusses sex differences in ...

The following are key points to remember from a review on nonsurgical management of chronic venous insufficiency (CVI): ...

In this week’s View, Dr. Eagle looks at what adult cardiologists should know about congenital heart disease patients. He then discusses sudden cardiac arrest and death in competitive and recreational ...